Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dual CLK/CDK1 inhibitors for cancer treatment

Dual CLK/CDK1 inhibitors for cancer treatment

US Patent 11337981 · Granted May 24, 2022

Estimated economic value: $12,000,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dual CLK/CDK1 inhibitors for cancer treatment2020
Dual CLK/CDK1 inhibitors for cancer treatment2020
Dual CLK/CDK1 inhibitors for cancer treatment2020
MAP4K4 (HGK) inhibitors2018
Anticancer compounds2017
Anticancer compounds2017
Pyrimidinone compounds and methods for treating influenza2016
Anticancer compounds and methods of making and using same2015
Anticancer compounds and methods of making and using same2015
Heterocyclic compounds useful in the treatment of neoplastic diseases, inflammat2014
Pyrimidinyl pyridone inhibitors of kinases2012
Tricyclic compound derivatives useful in the treatment of neoplastic diseases, i2011